PDGFR Inhibitors

PDGFR

PDGFRβ

PDGFRα

PDGFR Inhibitors & Modulators

Product Name	PDGFR	PDGFRβ	PDGFRα	Purity
Lenvatinib		PDGFRβ, IC₅₀: 39 nM	PDGFRα, IC₅₀: 51 nM	99.85%
Nintedanib		PDGFRβ, IC₅₀: 65 nM	PDGFRα, IC₅₀: 59 nM	99.94%
Regorafenib		PDGFRβ, IC₅₀: 22 nM		99.93%
Sunitinib		PDGFRβ, IC₅₀: 2 nM		99.04%
Ponatinib			PDGFRα, IC₅₀: 1.1 nM	99.67%
Axitinib		PDGFRβ, IC₅₀: 1.6 nM		99.94%
Pazopanib		PDGFRβ, IC₅₀: 84 nM		99.91%
SU 5402		PDGFRβ, IC₅₀: 510 nM		99.86%
Nintedanib esylate		PDGFRβ, IC₅₀: 65 nM	PDGFRα, IC₅₀: 59 nM	99.96%
Lenvatinib mesylate		PDGFRβ, IC₅₀: 39 nM	PDGFRα, IC₅₀: 51 nM	99.86%
CP-673451		PDGFRβ, IC₅₀: 1 nM	PDGFRα, IC₅₀: 10 nM	99.69%
Crenolanib		PDGFRβ, Kd: 3.2 nM	PDGFRα, Kd: 2.1 nM	99.68%
Sunitinib Malate		PDGFRβ, IC₅₀: 2 nM		99.86%
Ripretinib			PDGFRA	98.90%
Linifanib		PDGFRβ, IC₅₀: 66 nM		99.28%
Cediranib		PDGFRβ, IC₅₀: 5 nM	PDGFRα, IC₅₀: 36 nM	99.87%
Dovitinib		PDGFRβ, IC₅₀: 27 nM	PDGFRα, IC₅₀: 210 nM	99.88%
Pazopanib Hydrochloride		PDGFRβ, IC₅₀: 84 nM		99.99%
CHIR-124	PDGFR, IC₅₀: 6.6 nM			99.05%
Regorafenib monohydrate		PDGFRβ, IC₅₀: 22 nM		99.96%
Ponatinib hydrochloride			PDGFRα, IC₅₀: 1.1 nM	99.76%
Orantinib		PDGFRβ, Ki: 8 nM		99.29%
Regorafenib Hydrochloride		PDGFRβ, IC₅₀: 22 nM		99.58%
PP121	PDGFR, IC₅₀: 2 nM			99.51%
M4205		PDGFRβ, IC₅₀: 2.6 nM	PDGFRA, IC₅₀: 50 nM	99.47%
Amuvatinib			PDGFRα^V561D, IC₅₀: 40 nM PDGFRα^D842V, IC₅₀: 81 nM	99.40%
SU14813		PDGFRβ, IC₅₀: 4 nM		99.11%
Tyrphostin AG1296		PDGFRβ	PDGFRα	99.69%
Telatinib			PDGFRα, IC₅₀: 15 nM	99.37%
Toceranib		PDGFRβ, Ki: 5 nM
Ilorasertib hydrochloride		PDGFRβ, IC₅₀: 13 nM	PDGFRα, IC₅₀: 11 nM	98.48%
Methylnissolin	PDGFR, IC₅₀: 10 μM			99.86%
PP58	PDGFR			99.75%
ENMD-2076			PDGFRα, IC₅₀: 56.4 nM	99.99%
Seralutinib		PDGFRβ	PDGFRα	99.94%
TAK-593		PDGFRβ, IC₅₀: 13 nM	PDGFRα, IC₅₀: 4.3 nM PDGFRα^V561D, IC₅₀: 1 nM	99.66%
SU4312	PDGFR			99.76%
Famitinib		PDGFRβ, IC₅₀: 6.6 nM		98.13%
SU16f		PDGFRβ, IC₅₀: 10 nM		99.36%
JNJ-10198409		PDGFRβ, IC₅₀: 4.2 nM	PDGFRα, IC₅₀: 45 nM	99.58%
Tandutinib	PDGFR, IC₅₀: 0.2 μM			99.48%
Cediranib maleate		PDGFRβ, IC₅₀: 5 nM	PDGFRα, IC₅₀: 36 nM	99.95%
PDGFRα kinase inhibitor 1		PDGFRβ, IC₅₀: 6115 nM	PDGFRα, IC₅₀: 132 nM	98.51%
Chiauranib		PDGFRβ, IC₅₀: 93 nM	PDGFRα, IC₅₀: 1 nM	99.28%
PD-161570	PDGFR, IC₅₀: 310 nM	PDGFRβ, IC₅₀: 262 nM		99.82%
JI-101		PDGFRβ		99.78%
SU14813 maleate		PDGFRβ, IC₅₀: 4 nM		99.04%
Toceranib phosphate		PDGFRβ, Ki: 5 nM		98.54%
Tovetumab			PDGFRα	99.49%
TG 100801		PDGFRβ, IC₅₀: 13 nM		98.61%
Zeteletinib	PDGFR2			98.31%
TG 100572 Hydrochloride		PDGFRβ, IC₅₀: 13 nM		98.76%
Ilorasertib		PDGFRβ, IC₅₀: 13 nM	PDGFRα, IC₅₀: 11 nM	99.86%
Dovitinib lactate		PDGFRβ, IC₅₀: 210 nM	PDGFRα, IC₅₀: 27 nM	99.75%
Multi-kinase inhibitor 1	PDGFR			99.34%
ENMD-2076 Tartrate			PDGFRα, IC₅₀: 56.4 nM	99.42%
PDGFRα kinase inhibitor 2	PDGFR, IC₅₀: 1.39 μM			98.95%
(Z)-Orantinib		PDGFRβ, IC₅₀: 0.008 μM		99.44%
Tandutinib hydrochloride	PDGFR, IC₅₀: 0.2 μM			99.78%
HG-7-85-01			PDGFRα, IC₅₀: 440 nM	99.94%
PD-089828		PDGFR-β, IC₅₀: 1.76 μM PDGFR-β, Ki: 2.38 μM		98.07%
Flumatinib mesylate		PDGFRβ, IC₅₀: 307.6 nM		99.80%
AZD2932		PDGFRβ, IC₅₀: 4 nM		99.04%
AXL-IN-13		PDGFRβ, Kd: 2.3 nM		98.03%
XL 999			PDGFRα, IC₅₀: 4 nM	99.01%
AC710		PDGFRβ, Kd: 1 nM	PDGFRα, Kd: 1.3 nM	99.13%
GZD856 (formic)		PDGFRβ, IC₅₀: 136.6 nM	PDGFRα, IC₅₀: 68.6 nM
Tyrphostin AG1433		PDGFRβ, IC₅₀: 5 μM		99.08%
Hypothemycin		PDGFRβ, Ki: 900 nM	PDGFRα, Ki: 1.5 μM	≥98.0%
Telatinib mesylate			PDGFRα, IC₅₀: 15 nM	99.74%
NVP-ACC789		PDGFR-β, IC₅₀: 1.4 μM		99.52%
Sunitinib-d₁₀		PDGFRβ, IC₅₀: 2 nM		99.89%
AG 370	PDGFR, IC₅₀: 20 μM
KG5		PDGFRβ, Kd: 520 nM	PDGFRα, Kd: 300 nM	99.79%
Ponatinib-d₈			PDGFRα, IC₅₀: 1.1 nM	99.91%
BMS-605541		PDGFR-β, IC₅₀: 200 nM		99.57%
SU-4313	PDGFR, IC₅₀: 14.5 μM			99.31%
TG 100572		PDGFRβ, IC₅₀: 13 nM
Dovitinib lactate hydrate		PDGFRβ, IC₅₀: 210 nM	PDGFRα, IC₅₀: 27 nM
Regorafenib mesylate		PDGFRβ, IC₅₀: 22 ± 3 nM
SU 5402 (GMP)		PDGFRβ, IC₅₀: 510 nM
Zeteletinib hemiadipate	PDGFR2
Famitinib malate		PDGFRβ, IC₅₀: 6.6 nM
Multi-kinase-IN-1			PDGFRα, IC₅₀: 0.384 μM
Multi-kinase inhibitor 4		PDGFRβ, IC₅₀: 0.89 nM	PDGFRα, IC₅₀: 0.18 nM
Ki11502		PDGFRβ, IC₅₀: <10 nM	PDGFRα, IC₅₀: <10 nM	99.30%
Multi-kinase-IN-3		PDGFRβ, IC₅₀: 55 ± 2.6 nM
SA-PA		PDGFR-β
Henatinib		PDGFRβ	PDGFRα
IHMT-TRK-284		PDGFRβ, IC₅₀: 95.7 nM	PDGFRα, IC₅₀: 24.2 nM
Antifibrotic agent 1			PDGFRα
HSN748		PDGFRβ	PDGFRα
Multi-kinase-IN-5	PDGFR
Multi-kinase inhibitor 3		PDGFR-β, IC₅₀: 1.15 nM	PDGFRα, IC₅₀: 0.22 nM
WQ-C-401		PDGFRβ, EC₅₀: 5.8 nM	PDGFRα, EC₅₀: 3.5 nM
Multi-kinase-IN-2		PDGFRβ, IC₅₀: 9.9 ± 0.7 nM	PDGFRα, IC₅₀: 7.0 ± 0.1 nM
TG 100801 Hydrochloride		PDGFRβ, IC₅₀: 13 nM
VEGFR-2-IN-44		PDGFR-β, IC₅₀: 920 nM
AC710 Mesylate		PDGFRβ, Kd: 1 nM	PDGFRα, Kd: 1.3 nM
GZD856		PDGFRβ, IC₅₀: 136.6 nM	PDGFRα, IC₅₀: 68.6 nM
Amuvatinib hydrochloride			PDGFRα^V561D, IC₅₀: 40 nM PDGFRα^D842V, IC₅₀: 81 nM

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2025 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4